Omar Aljitawi is an Oncology physician affiliated with University of Rochester Medicine. OpenAlex indexes 197 publications with 2,791 citations (h-index 22); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave
Rochester, NY 146420001
Telephone
585-275-5823Registry record last updated 29 Jun 2023.
Clinical trials
- Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT
Sponsor: University of Rochester
- Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
Sponsor: Omar Aljitawi
- A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
Sponsor: University of Rochester
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year20222 payments
- Acrotech Biopharma LLCProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
23.8%Proton pump inhibitor11%Pantoprazole Sodium100%Part D≥17 patientsCorticosteroid10.5%Prednisone100%Part D≥18 patients+ 1 more class in this area
Dermatology
18.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor13.6%Acyclovir100%Part D≥22 patientsCorticosteroid5.2%Triamcinolone Acetonide56%Methylprednisolone44%Part D<11 patientsCancer & immunology
17.6%Kinase inhibitor17.6%Jakafi100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:
- Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
University of Rochester
FY2022$347,581R37CA225791 - Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
University of Rochester
FY2021$347,581R37CA225791 - Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
University of Rochester
FY2020$352,275R37CA225791
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril
International Journal of Radiation Oncology*Biology*Physics
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Beck, MD
University of Rochester Medicine
Benzi Kluger, MD
University of Rochester Medicine
Darren Tabechian, MD
University of Rochester Medicine
Ayesa Mian, MD
University of Rochester Medicine
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”